Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
CTNM on Nasdaq
There are no Buy or Sell transactions made by Versant Venture Capital VI, L.P. since 31 Jan 2025
Holdings reported by Versant Venture Capital VI, L.P. for Contineum Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Class A Common Stock |
375,535 |
$6,402,872 |
$17.05 |
09 Apr 2024 |
Direct |
|
|
| Class A Common Stock |
148,312 |
$2,528,720 |
$17.05 |
09 Apr 2024 |
Indirect |
|
|
| Series B Preferred Stock |
1,741,107 |
|
|
09 Apr 2024 |
Direct |
Class B Common Stock |
|
| Series A-1 Preferred Stock |
1,423,119 |
|
|
09 Apr 2024 |
Direct |
Class B Common Stock |
|
| Series C Preferred Stock |
710,494 |
|
|
09 Apr 2024 |
Indirect |
Class B Common Stock |
|
| Series B Preferred Stock |
434,725 |
|
|
09 Apr 2024 |
Indirect |
Class B Common Stock |
|
| Series A Preferred Stock |
9,252 |
|
|
09 Apr 2024 |
Indirect |
Class B Common Stock |
|
Transactions reported by Versant Venture Capital VI, L.P. for Contineum Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.